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Objectives: Chronic lumbosacral radicular pain has significant morbidity and burden 
to the society. The objective of this study was to assess the functional disability and 
factors affecting it in patients with chronic lumbosacral radicular pain. MethOds: We 
performed an observational cross sectional study in a public tertiary care hospital in 
north India. Adult patients (18 and 75 years), with > 12 weeks of low back pain, without 
any co-morbidities were included in this study. Data regarding socio-demographics, 
duration of low back pain, prescribing pattern and depression collected at baseline. 
Pain assessed using visual analogue scale (VAS), functional disability using modified 
oswesrty disability questionnaire (MODQ). Patients also asked for health care utiliza-
tion at the end of study. Predictors of high disability were analysed using multivariate 
regression analysis. Results: A total of 246 patients (51% males and 49% females) with 
mean age of 44.9 (12.25) years were included for final analysis. Mean VAS and MODQ 
scores at baseline are 72.3+12.5 and 48.3+11.2 respectively. Based on disability scores, 
62% of patients found to be crippled whereas 62% and 24% of patients fall in severe 
and moderate disability category respectively. VAS and MODQ scores were positively 
correlated (r= 0.84, p< 0.05). Multi factorial analysis reveals that severe pain (higher 
VAS scores), high duration of pain, older age, over-weight, patients from urban region 
and depression were significantly associated with high disability. cOnclusiOns: 
Our study results suggest that chronic lumbosacral radicular pain patients suffer with 
sever disability. Severity of pain was significantly correlated with levels of disability.
PRM3
hieRaRchical netWoRk Meta-analysis incoRPoRating oRdeRing 
constRaints on incReasing doses of inteRventions - aPPlication to 
oveRactive bladdeR syndRoMe
Owen R.K., Tincello D.G., Bujkiewicz S., Abrams K.
University of Leicester, Leicester, UK
bAckgROund: For the conservative treatment of Overactive Bladder (OAB) 
symptoms, the National Institute for Health and Care Excellence (NICE) in the 
UK currently recommends a course of supervised pelvic floor muscle training, 
behavioural therapy, anticholinergic medication, sacral nerve stimulation, and 
more recently, botulinum toxin type A (BoNTA) and Mirabegron. Given the large 
number of interventions and relatively few primary trials, network meta-analy-
ses (NMAs) produce considerable uncertainty in the estimated treatment effects 
and consequently, there is little evidence of the most clinically effective inter-
vention. Objectives: To evaluate the use of hierarchical NMAs incorporating 
ordering constraints on increasing doses in order to identify the most effective 
intervention for the treatment of OAB symptoms. MethOds: Using Bayesian 
Markov Chain Monte Carlo methods, we apply a 3-level hierarchical NMA that 
accounts for both the correlation between treatments within the same class, as 
well as the residual between-study heterogeneity. We further extend this model 
to incorporate ordering constraints on increasing doses of the same interven-
tion. We apply the methods to a dataset obtained from a systematic literature 
review of randomised controlled trials evaluating interventions for OAB syndrome. 
The primary outcomes of interest were mean change from baseline for void-
ing, urgency, and incontinence episodes. Results: The dataset includes 78 trials 
comparing 39 interventions that can be further categorised into 10 classes of 
interventions, including placebo. For voiding, and urgency episodes, BoNTA 200u 
was the most effective intervention with estimated mean reduction of -2.24 (95% 
CrI: -2.95, -1.48), and -2.6 (95% CrI: -3.46, -1.7) episodes relative to placebo, respec-
tively. BoNTA 300u was the most effective intervention for reducing incontinence 
episodes with an estimated mean reduction of -1.81 (95% CrI: -2.39, -1.33) epi-
sodes relative to placebo. cOnclusiOns: Use of hierarchical NMAs, incorporating 
ordering constraints, increases the precision in the effect estimates but maintains 
the interpretability of individual interventions. BoNTA was found to be the most 
effective intervention for reducing symptoms of OAB.
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Objectives: Using randomized clinical trials (RCTs) for clinical decision-making 
necessitates making decisions for individuals based on average treatment effects. 
While many assume important patient variation in treatment effects, identifying 
patients most likely to benefit is problematic. Stratifying patients by their risk 
of the primary outcome was proposed as a method to identify high versus low 
benefit patients. MethOds: From publically available sources, we identified 13 
large RCTs with greater than ~1000 enrollees and overall statistically significant 
results. We derived Cox or logistic regression models using established risk fac-
tors blinded to treatment assignment and stratified the patient population into 
quartiles of risk for the outcome. Treatment effect within each risk quartile was 
estimated on relative and absolute scales. Heterogeneity of treatment effect (HTE) 
was evaluated statistically by testing for an interaction between treatment and 
the linear predictor of risk, and by comparing hazard (or odds) ratios and abso-
lute risk reduction in the extreme risk quartiles. Results: Among 19 unique 
treatment comparisons analyzed, there was no apparent relationship between 
baseline risk and the hazard (or odds) ratios across trials; only 1 of 19 analyses 
had a significant interaction between treatment and baseline risk on the pro-
portional scale. The difference in the log hazard ratio between the extreme risk 
quartiles ranged from -0.89 to 0.60 (median= 0.03; inter-quartile range (IQR) = -0.4-
corticosteroids were more widely used (46.5%/26.8% vs. 12.3%/11.0%) and retinoids 
were less commonly used (5.1% vs. 18.0%). UK physicians were less likely to pre-
scribe a biologic-treatment before trying > = 1 other systemic-treatment (1.8% vs. 8.5%), 
and to wait longer after diagnosis to initiate biologic-therapy (25.8movs. 20.1mo); 
in Germany, patients were more likely to have tried 3-5 other systemic-treatments 
before initiating biologic-treatment (28.0% vs. 14.2%); patients in France were the most 
likely to initiate a biologic without trying another systemic-treatment first (11.2% vs. 
8.5%). Patients in Germany were started on biologics later on average (25.8mo after 
diagnosis vs. 14.0mo). The average flares in past-year was highest in Germany (1.4 
vs. 0.9). Average current PASI-score (26.4 vs. 16.0) and BSA-score (22.8 vs. 19.5) were 
highest in Germany. In France, 41.2% of patients had not had a PASI score done past 
year (vs. 23.3%). In Germany, 56.0% of patients had severe/terminal disease severity 
at biologic-therapy-initiation (vs. 47.8%). cOnclusiOns: Among psoriasis patients 
receiving their first biologic-therapy, treatment patterns and disease severity varied 
across the EU5. Factors influencing the observed variations in treatment patterns and 
outcomes warrant further scrutiny to decrease patient disease burden.
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Objectives: Exposition to microwave radiation (MW), from mobile phones, satellite 
communications, radio relays, radars and microwave devices in medicine induce 
disturbances in thymus. The pineal secretory product, melatonin (Mel), exerts a 
veriety of effects on the immune system. The aim of the present study was to 
evaluate the effect of melatonin on apoptosis and oxidative stress parametars in 
thymus tissue of rats after 40 days long exposure to MWs. MethOds: Wister rats 
were divided in 4 experimental groups: I (control), II (Mel group) - rats treated with 
Mel every day (2 mg/kg b.w., i.p), III (MW group) - rats exposed to MW (4 h/day), IV 
(MW+Mel) - rats treated with Mel every day (2 mg/kg b.w., i.p) and exposed to MW 
radiation (4 h/day). Ten animals from 4 group were successively sacrificed after 40 
days of the experiment. MW was produced by a mobile test phone (SAR = 0.043-
0.135 W/kg). Results: The current study results demonstrate that MW significantly 
increased thymocyte apoptosis, detected using the Annexin V-FITC/PI detection kit 
(p< 0.001). DNA fragmentation in thymocytes injury of MW is probably triggered by 
the increase activation of alkaline-DNase I (caspase 3-activated) and acid-DNase II 
(p< 0.05). A significant increase in the thymus malondialdehyde (MDA) and carbonyl 
group concentration (p< 0.001), and decreased activity of catalase (p< 0.001) was 
registered during exposure. Melatonin was found to be effective on rat thymocyte: 
(1) decreased apoptotic rate of thymocytes (p< 0.001), (2) effect on terminal apop-
totic reaction, because of the decrease DNase I and DNase II activity (p< 0.01), (3) 
decreased MDA and carbonyl group levels (p< 0.01), (4) increase activity of catalase 
(p< 0.05), comparated with MW group. cOnclusiOns: Having in the mind obtained 
results we can conclude that melatonine exerts protective effects on rat thymocyte 
by preventing apoptosis and oxidative stress disturbances in rats’ thymus under 
exposure of MW.
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Objectives: To explore the existence and clinical implications of symptomatic 
factors in patients with major depressive episodes. MethOds: Data are from a 
6-month prospective, non-interventional, observational study that included 1,549 
MDD patients without sexual dysfunction in twelve countries. Depression severity 
was measured using the Clinical Global Impression (CGI) and the 16-item Quick 
Inventory of Depressive Symptomatology Self-Report (QIDS-SR16). Pain and qual-
ity of life were measured using the pain related items of the Somatic Symptom 
Inventory (SSI) and the EuroQoL-5D, respectively. The QIDS-SR16and the SSI items 
were jointly included in a factor analysis. Exploratory factor analysis (EFA) was 
conducted in a randomly selected half of the sample and confirmatory factor 
analysis (CFA) in the remaining half. Results: The EFA showed that a four factor 
model explained the data apropriately (RMSEA 0.041, 90%CI 0.034- 0.048; CFI 0.979). 
The four factors were mood (feeling sad, concentration/decision making, self criti-
cism, suicidal thoughts, interest in people or activities, energy/fatigability, psycho-
motor retardation and agitation); sleep (initial, middle insomnia, early awakening 
and sleeping too much); appetite and weight, and pain (muscle soreness, cramps in 
abdomen, pain in lower back, pain in heart or chest, pain in joints, neck pain, head-
ache). The CFA showed good fit indexes for this four-factor model (RMSA 0.054, 90% 
CI 0.049-0.059; CFI 0.954). There was a highly statistical significant correla-
tion (Spearman) between each of the four factors and CGI severity score and 
quality of life at each of the visits, with higher scores in the factors (higher 
severity) associated with higher CGI and lower quality of life (p< 0.001, all com-
parisons). cOnclusiOns: Considering the results presented, the data reason-
ably support that pain symptoms be included in the evaluation of patients with 
major depression. More severe pain symptoms are associated to higher severity 
of depression and lower quality of life.
